RA CAPITAL MANAGEMENT, L.P. - 18 Aug 2023 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
10%+ Owner
Signature
/s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
Issuer symbol
ANTX
Transactions as of
18 Aug 2023
Net transactions value
+$16,000,002
Form type
4
Filing time
22 Aug 2023, 17:01:31 UTC
Previous filing
09 Aug 2023
Next filing
31 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Purchase $16,000,002 +1,777,778 +53% $9.00 5,135,683 18 Aug 2023 See Footnotes F1, F2, F3
holding ANTX Common Stock 415,612 18 Aug 2023 See Footnotes F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired from the Issuer pursuant to the public offering described in the Issuer's Prospectus filed with the Securities and Exchange Commission on August 16, 2023.
F2 RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus Fund II, L.P. (the "Nexus Fund II"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.
F3 Held directly by the Fund.
F4 Held directly by the Nexus Fund II.